Holen Sie sich die Stockscreener-App
4.72
3.28%
0.15
Handel nachbörslich:
4.73
0.01
+0.21%
Schlusskurs vom Vortag:
$4.57
Offen:
$4.6
24-Stunden-Volumen:
3.76M
Relative Volume:
0.66
Marktkapitalisierung:
$1.41B
Einnahmen:
$38.03M
Nettoeinkommen (Verlust:
$-146.40M
KGV:
-9.0769
EPS:
-0.52
Netto-Cashflow:
$-121.38M
1W Leistung:
+2.39%
1M Leistung:
+1.07%
6M Leistung:
+100.85%
1J Leistung:
+71.64%
1-Tages-Spanne:
$4.5999
$4.79
1-Wochen-Bereich:
$4.32
$4.85
52-Wochen-Spanne:
$1.8906
$5.82
Abcellera Biologics Inc Stock (ABCL) Company Profile
Firmenname
Abcellera Biologics Inc
Sektor
Branche
Telefon
(604) 559-9005
Adresse
150 W 4TH AVENUE, VANCOUVER
Vergleichen Sie ABCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
4.72 | 1.37B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-02-28 | Eingeleitet | Cowen | Outperform |
| 2022-12-15 | Eingeleitet | Goldman | Buy |
| 2022-11-16 | Eingeleitet | Truist | Buy |
| 2021-12-21 | Eingeleitet | The Benchmark Company | Buy |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Eingeleitet | Berenberg | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-05 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | Stifel | Buy |
Alle ansehen
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
AbCellera Biologics Inc. (ABCL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Published on: 2025-09-17 05:48:40 - newser.com
AbCellera Biologics (NASDAQ:ABCL) Trading Up 7.6%Should You Buy? - MarketBeat
Salem Investment Counselors Inc. Reduces Stock Position in AbCellera Biologics Inc. $ABCL - MarketBeat
AbCellera Biologics Inc. $ABCL Shares Purchased by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Forecasting AbCellera Biologics Inc. price range with options dataJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Is AbCellera Biologics Inc. forming a bottoming base2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Fed Meeting: Can AbCellera Biologics Inc maintain its current growth rate2025 Market WrapUp & Precise Swing Trade Entry Alerts - خودرو بانک
Stock Analysis: Can AbCellera Biologics Inc disrupt its industryWeekly Risk Summary & Verified Chart Pattern Trade Signals - خودرو بانک
What candlestick patterns are forming on AbCellera Biologics Inc.Trade Risk Summary & Technical Pattern Based Signals - newser.com
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 - Yahoo Finance
12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds - Insider Monkey
Published on: 2025-09-14 20:30:45 - newser.com
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer - BioSpace
AbCellera Biologics Appoints New Chief Medical Officer - TipRanks
AbCellera appoints Sarah Noonberg as first Chief Medical Officer By Investing.com - Investing.com Nigeria
AbCellera appoints Sarah Noonberg as first Chief Medical Officer - Investing.com
AbCellera appoints Sarah Noonberg as Chief Medical Officer - TipRanks
Abcellera appoints Dr. Sarah Noonberg as Chief Medical Officer - MarketScreener
3 Promising Penny Stocks With Market Caps Under $2B - simplywall.st
Bollinger Band Squeeze Points to Volatility in AbCellera Biologics Inc.2025 Market Sentiment & Capital Protection Trading Alerts - beatles.ru
Bullish AbCellera Biologics Insiders Loaded Up On US$940.3k Of Stock - Yahoo Finance
Ichimoku Cloud Indicates Uncertainty Around AbCellera Biologics Inc.2025 Big Picture & Entry Point Confirmation Alerts - beatles.ru
Identifying reversal signals in AbCellera Biologics Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - Newser
Published on: 2025-09-06 12:54:41 - Newser
What the charts say about AbCellera Biologics Inc. todayJuly 2025 Fed Impact & Weekly Setup with ROI Potential - Newser
Will AbCellera Biologics Inc. outperform the marketFed Meeting & Daily Market Momentum Tracking - Newser
Published on: 2025-09-05 14:09:11 - Newser
Is AbCellera Biologics Inc. stock reversal real or fakeJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - Newser
AbCellera at Wells Fargo Conference: Strategic Pipeline Expansion By Investing.com - Investing.com Canada
Can AbCellera Biologics Inc. keep up with sector leadersMarket Trend Review & Fast Momentum Stock Entry Tips - خودرو بانک
Volume spikes in AbCellera Biologics Inc. stock – what they meanEarnings Beat & High Accuracy Swing Entry Alerts - Newser
How does AbCellera Biologics Inc. score in quality rankingsWeekly Investment Report & Weekly High Return Forecasts - خودرو بانک
Chart overlay techniques for tracking AbCellera Biologics Inc.2025 Historical Comparison & Stock Portfolio Risk Management - Newser
What is AbCellera Biologics Inc. s P E ratio telling usDip Buying & Free Community Consensus Stock Picks - خودرو بانک
Is AbCellera Biologics Inc.’s ROIC above industry averageJuly 2025 Catalysts & Expert Curated Trade Setups - خودرو بانک
Trend analysis for AbCellera Biologics Inc. this weekJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Can a trend reversal in AbCellera Biologics Inc. lead to recoveryQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
How to recover losses in AbCellera Biologics Inc. stockJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
Using economic indicators to assess AbCellera Biologics Inc. potentialAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Analyzing drawdowns of AbCellera Biologics Inc. with statistical toolsRisk Management & Reliable Volume Spike Trade Alerts - Newser
Applying Elliott Wave Theory to AbCellera Biologics Inc.July 2025 Rallies & Verified Entry Point Detection - Newser
Applying big data sentiment scoring on AbCellera Biologics Inc.Product Launch & Fast Momentum Entry Tips - Newser
Can machine learning forecast AbCellera Biologics Inc. recoveryJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
AbCellera Biologics Inc.’s volatility index tracking explainedAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Has AbCellera Biologics Inc. formed a bullish divergenceMarket Growth Review & Step-by-Step Trade Execution Guides - Newser
Chart based analysis of AbCellera Biologics Inc. trendsWeekly Gains Report & Community Consensus Trade Alerts - Newser
How to build a dashboard for AbCellera Biologics Inc. stockMarket Activity Report & Low Risk Profit Maximizing Plans - Newser
What indicators show strength in AbCellera Biologics Inc.Trade Performance Summary & AI Optimized Trade Strategies - Newser
Is AbCellera Biologics Inc. affected by consumer sentiment2025 Major Catalysts & Verified Momentum Watchlists - خودرو بانک
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):